Free Trial

Clearside Biomedical (CLSD) Competitors

Clearside Biomedical logo
$0.50 -0.04 (-7.72%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$0.50 0.00 (-0.04%)
As of 07/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLSD vs. GNLX, MCRB, PLX, SKYE, ONCY, FTLF, TARA, HURA, BHST, and ACTU

Should you be buying Clearside Biomedical stock or one of its competitors? The main competitors of Clearside Biomedical include Genelux (GNLX), Seres Therapeutics (MCRB), Protalix BioTherapeutics (PLX), Skye Bioscience (SKYE), Oncolytics Biotech (ONCY), FitLife Brands (FTLF), Protara Therapeutics (TARA), TuHURA Biosciences (HURA), BioHarvest Sciences (BHST), and Actuate Therapeutics (ACTU). These companies are all part of the "pharmaceutical products" industry.

Clearside Biomedical vs. Its Competitors

Genelux (NASDAQ:GNLX) and Clearside Biomedical (NASDAQ:CLSD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Genelux has a net margin of 0.00% compared to Clearside Biomedical's net margin of -818.57%. Clearside Biomedical's return on equity of 0.00% beat Genelux's return on equity.

Company Net Margins Return on Equity Return on Assets
GeneluxN/A -93.04% -74.17%
Clearside Biomedical -818.57%N/A -114.23%

In the previous week, Clearside Biomedical had 5 more articles in the media than Genelux. MarketBeat recorded 7 mentions for Clearside Biomedical and 2 mentions for Genelux. Genelux's average media sentiment score of 0.94 beat Clearside Biomedical's score of 0.18 indicating that Genelux is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Genelux
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clearside Biomedical
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Genelux has higher earnings, but lower revenue than Clearside Biomedical. Genelux is trading at a lower price-to-earnings ratio than Clearside Biomedical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genelux$10K12,611.84-$29.87M-$0.88-3.80
Clearside Biomedical$1.66M23.28-$34.35M-$0.41-1.21

Genelux currently has a consensus target price of $17.75, suggesting a potential upside of 431.44%. Clearside Biomedical has a consensus target price of $4.20, suggesting a potential upside of 744.73%. Given Clearside Biomedical's higher probable upside, analysts plainly believe Clearside Biomedical is more favorable than Genelux.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Genelux
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20
Clearside Biomedical
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17

Genelux has a beta of -0.34, suggesting that its share price is 134% less volatile than the S&P 500. Comparatively, Clearside Biomedical has a beta of 2.05, suggesting that its share price is 105% more volatile than the S&P 500.

37.3% of Genelux shares are held by institutional investors. Comparatively, 18.8% of Clearside Biomedical shares are held by institutional investors. 9.3% of Genelux shares are held by insiders. Comparatively, 6.2% of Clearside Biomedical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Genelux beats Clearside Biomedical on 10 of the 17 factors compared between the two stocks.

Get Clearside Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLSD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLSD vs. The Competition

MetricClearside BiomedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$41.87M$3.06B$5.69B$9.50B
Dividend YieldN/A2.37%4.58%4.01%
P/E Ratio-1.2121.1828.1020.05
Price / Sales23.28288.50432.4490.07
Price / CashN/A42.7636.2258.56
Price / Book-0.978.378.665.87
Net Income-$34.35M-$55.19M$3.25B$258.55M
7 Day Performance21.27%5.88%4.23%3.74%
1 Month Performance-38.69%17.33%10.52%11.75%
1 Year Performance-57.50%4.42%34.41%18.03%

Clearside Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLSD
Clearside Biomedical
2.0443 of 5 stars
$0.50
-7.7%
$4.20
+744.7%
-56.0%$41.87M$1.66M-1.2130
GNLX
Genelux
1.2346 of 5 stars
$3.51
+5.4%
$17.75
+405.7%
+74.0%$125.74M$10K-3.9910Analyst Forecast
MCRB
Seres Therapeutics
3.5129 of 5 stars
$13.85
-1.6%
$73.67
+431.9%
-46.6%$122.86M$126.32M-3.01330Positive News
PLX
Protalix BioTherapeutics
2.9323 of 5 stars
$1.52
+4.8%
$15.00
+886.8%
+31.3%$121.00M$59.76M-11.69200
SKYE
Skye Bioscience
2.4213 of 5 stars
$3.73
-4.1%
$16.60
+345.0%
-33.7%$120.49MN/A-4.5511News Coverage
ONCY
Oncolytics Biotech
1.6634 of 5 stars
$1.21
-4.7%
$4.33
+258.1%
+1.0%$119.74MN/A-4.1730News Coverage
Upcoming Earnings
FTLF
FitLife Brands
4.0839 of 5 stars
$12.97
+1.8%
$20.50
+58.1%
-23.6%$119.64M$64.47M15.4420News Coverage
TARA
Protara Therapeutics
2.1594 of 5 stars
$3.42
+11.0%
$20.50
+499.4%
+45.4%$118.83MN/A-1.9930Positive News
HURA
TuHURA Biosciences
1.7846 of 5 stars
$2.55
-2.7%
$12.67
+396.7%
N/A$114.44MN/A0.00N/A
BHST
BioHarvest Sciences
N/A$6.84
-1.2%
$13.67
+99.8%
N/A$113.66M$25.19M-13.68N/ANews Coverage
ACTU
Actuate Therapeutics
2.252 of 5 stars
$5.66
-1.7%
$20.50
+262.2%
N/A$113.01MN/A0.0010News Coverage

Related Companies and Tools


This page (NASDAQ:CLSD) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners